loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Prestwick3_000234, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Prestwick3_000234

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Forms

    MARKET PLACE

    DIGITAL CONTENT

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    2D Structure
    Also known as: 886-74-8, Maolate, Rinlaxer, 3-(4-chlorophenoxy)-2-hydroxypropyl carbamate, 3-(p-chlorophenoxy)-1,2-propanediol 1-carbamate, 3-(p-chlorophenoxy)-2-hydroxypropyl carbamate
    Molecular Formula
    C10H12ClNO4
    Molecular Weight
    245.66  g/mol
    InChI Key
    SKPLBLUECSEIFO-UHFFFAOYSA-N
    FDA UNII
    G014XC07GH
    Chlorphenesin Carbamate is the carbamate ester form of chlorphenesin, a preservative agent and centrally-acting muscle relaxant with some anti-bacterial and anti-fungal, muscle relaxing and potential antineoplastic activities. Although the exact mechanism of action (MoA) has yet to be fully elucidated, chlorphenesin may inhibit tumor cell proliferation and metastasis.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    [3-(4-chlorophenoxy)-2-hydroxypropyl] carbamate
    2.1.2 InChI
    InChI=1S/C10H12ClNO4/c11-7-1-3-9(4-2-7)15-5-8(13)6-16-10(12)14/h1-4,8,13H,5-6H2,(H2,12,14)
    2.1.3 InChI Key
    SKPLBLUECSEIFO-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    C1=CC(=CC=C1OCC(COC(=O)N)O)Cl
    2.2 Other Identifiers
    2.2.1 UNII
    G014XC07GH
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. 886-74-8

    2. Maolate

    3. Rinlaxer

    4. 3-(4-chlorophenoxy)-2-hydroxypropyl Carbamate

    5. 3-(p-chlorophenoxy)-1,2-propanediol 1-carbamate

    6. 3-(p-chlorophenoxy)-2-hydroxypropyl Carbamate

    7. Chlorphensin Carbamate

    8. Chlorphenesincarbamate

    9. 3-(4-chlorophenoxy)-1,2-propanediol-1-carbamate

    10. U-19,646

    11. 1,2-propanediol, 3-(4-chlorophenoxy)-, 1-carbamate

    12. Nsc 82943

    13. Carbamic Acid, 3-(p-chlorophenoxy)-2-hydroxypropyl Ester

    14. [3-(4-chlorophenoxy)-2-hydroxypropyl] Carbamate

    15. 3-(p-chlorophenoxy)-1,2-propanediol-1-carbamate

    16. U 19646

    17. 1,2-propanediol, 3-(p-chlorophenoxy)-, 1-carbamate

    18. Nsc-82943

    19. Hqc4wi89yg

    20. 1,2-propanediol,3-(4-chlorophenoxy)-, 1-carbamate

    21. Carbamic Acid 3-(p-chlorophenoxy)-2-hydroxypropyl Ester

    22. 57u5yi11wp

    23. Chebi:3643

    24. Chlorphenesin Carbamate, (-)-

    25. 1,2-propanediol-3-(p-chlorophenoxy)-1-carbamate

    26. Nsc82943

    27. Kolpicortin-sine

    28. (3-p-chlorophenoxy)-2-hydroxypropylcarbamate

    29. U-19646

    30. 1,2-propanediol, 3-(4-chlorophenoxy)-, 1-carbamate, (-)-

    31. Maolate; Nsc 82943; Rhnesicn; Rinlaxer; U 19646; U-19,646

    32. 126632-50-6

    33. Hsdb 3031

    34. Chlorphenesin Carbamate [usan:jan]

    35. Einecs 212-954-7

    36. Brn 1978575

    37. Unii-57u5yi11wp

    38. Ncgc00016548-01

    39. Cas-886-74-8

    40. Prestwick_882

    41. Maolate (tn)

    42. Prestwick0_000234

    43. Prestwick1_000234

    44. Prestwick2_000234

    45. Prestwick3_000234

    46. Unii-hqc4wi89yg

    47. Dsstox_cid_2803

    48. Wln: Zvo1yq1or Dg

    49. Dsstox_rid_76735

    50. Dsstox_gsid_22803

    51. Schembl34492

    52. Bspbio_000307

    53. Mls002154243

    54. Spbio_002228

    55. Bpbio1_000339

    56. Chembl607710

    57. G014xc07gh

    58. Dtxsid5022803

    59. Glxc-26272

    60. Hms1568p09

    61. Hms2095p09

    62. Hms2232o23

    63. Hms3371a08

    64. Hms3712p09

    65. Chlorphenesin Carbamate [mi]

    66. Tox21_110487

    67. Chlorphenesin Carbamate [jan]

    68. Chlorphenesin Carbamate [hsdb]

    69. Chlorphenesin Carbamate [usan]

    70. Chlorphenesin Carbamate (jp17/usan)

    71. Ccg-220234

    72. Chlorphenesin Carbamate [mart.]

    73. Chlorphenesin Carbamate [vandf]

    74. Chlorphenesin Carbamate, (+)-

    75. Db14656

    76. Chlorphenesin Carbamate [who-dd]

    77. 1, 3-(p-chlorophenoxy)-, 1-carbamate

    78. Ncgc00179607-01

    79. Ncgc00179607-03

    80. 1, 3-(4-chlorophenoxy)-, 1-carbamate

    81. Smr001233511

    82. Chlorphenesin Carbamate [green Book]

    83. Db-057097

    84. Hy-107944

    85. Chlorphenesin Carbamate [orange Book]

    86. Cs-0030953

    87. Ft-0602972

    88. C07930

    89. D00770

    90. [3-(4-chlorophenoxy)-2-hydroxy-propyl] Carbamate

    91. Sr-01000841824

    92. 3-[(4-chlorophenyl)oxy]-2-hydroxypropyl Carbamate

    93. Sr-01000841824-2

    94. W-100393

    95. Brd-a39230911-001-03-7

    96. Q27106156

    97. 1,2-propanediol, 3-(4-chlorophenoxy)-, 1-carbamate, (+)-

    2.4 Create Date
    2005-03-25
    3 Chemical and Physical Properties
    Molecular Weight 245.66 g/mol
    Molecular Formula C10H12ClNO4
    XLogP31.2
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count4
    Rotatable Bond Count6
    Exact Mass245.0454856 g/mol
    Monoisotopic Mass245.0454856 g/mol
    Topological Polar Surface Area81.8 Ų
    Heavy Atom Count16
    Formal Charge0
    Complexity219
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count1
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Therapeutic Uses

    IT IS EMPLOYED TO DIMINISH SKELETAL MUSCLE SPASMS RESULTING FROM TRAUMA , INFLAMMATION, VERTEBRAL DISK SYNDROME, OSTEOARTHRITIS, AND RHEUMATOID ARTHRITIS.

    Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 860

    APPLICATION: CENTRALLY ACTIVE SKELETAL MUSCLE RELAXANT SIMILAR IN ITS ACTIONS TO METHOCARBAMOL...

    Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 860

    IT MAY BE USEFUL AS TEMPORARY ADJUNCT TO PHYSIOTHERAPY & OTHER APPROPRIATE MEASURES IN THE TREATMENT OF THE DISCOMFORT PRODUCED BY SKELETAL MUSCLE SPASM OF LOCAL ORIGIN.

    American Medical Association, AMA Department of Drugs, AMA Drug Evaluations. 3rd ed. Littleton, Massachusetts: PSG Publishing Co., Inc., 1977., p. 1026

    MEDICATION (VET): /USED/ AS AN ADJUNCT TO OTHER THERAPY FOR ACUTE INFLAMMATORY OR TRAUMATIC SKELETAL MUSCLE INVOLVEMENT INCLUDING SPRAINS & INTERVERTEBRAL DISC SYNDROMES.

    Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 108

    THESE DRUGS MAY TEMPORARILY ABATE SOME OF THE SYMPTOMS OF CEREBRAL PALSY, BUT THEY HAVE MINOR ROLE IN OVERALL MGMNT OF THIS DISEASE... ALL CENTRALLY ACTING MUSCLE RELAXANTS PRODUCE SOME SEDATION, AT LEAST AT HIGHEST DOSES EMPLOYED CLINICALLY. /MUSCLE RELAXANTS/

    Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 241

    4.2 Drug Warning

    PERSONS TAKING DRUG SHOULD NOT DRIVE, OPERATE MACHINERY, OR UNDERTAKE ACTIVITIES THAT REQUIRE ALERTNESS, JUDGMENT, OR MENTATION.

    Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 860

    ...PROBABLY HAS AN ADDICTION LIABILITY, AS DO OTHER CARBAMATES.

    Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 860

    VET: DO NOT ADMIN TO ANY ANIMAL WITH SIGNIFICANT LIVER PATHOLOGY. LIVER FUNCTION MAY BE ADVERSELY AFFECTED DURING ITS USE.

    Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 108

    5 Pharmacology and Biochemistry
    5.1 Absorption, Distribution and Excretion

    ORAL DOSES ARE READILY ABSORBED /IN ANIMALS/.

    Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 108

    MUCH OF DOSE OF CHLORPHENESIN CARBAMATE...IS RAPIDLY EXCRETED IN URINE OF RATS & OF MAN.

    The Chemical Society. Foreign Compound Metabolism in Mammals. Volume 1: A Review of the Literature Published Between 1960 and 1969. London: The Chemical Society, 1970., p. 175

    AFTER ORAL ADMIN OF (14)C-LABELED CHLORPHENESIN CARBAMATE TO RATS, IT WAS ABSORBED FROM GI TRACT; EXCRETED IN URINE ABOUT 90%; 36% IN BILE. RADIOACTIVITY WAS DISTRIBUTED IN ALMOST ALL TISSUES, HIGHEST IN LIVER, BRAIN & SPINAL CORD.

    NOZU T ET AL; OYO YAKURI 14(1) 1 (1977)

    5.2 Metabolism/Metabolites

    MAJOR METABOLITE (49% OF DOSE) IS ETHER GLUCURONIDE OF CHLORPHENESIN CARBAMATE...

    The Chemical Society. Foreign Compound Metabolism in Mammals. Volume 1: A Review of the Literature Published Between 1960 and 1969. London: The Chemical Society, 1970., p. 175

    5% APPEARED IN URINE AS P-CHLOROPHENOXYLACTIC ACID, 17% AS P-CHLOROPHENOXYACETIC ACID, AND 9% AS SULFATE CONJUGATE OF P-CHLOROPHENOL...

    The Chemical Society. Foreign Compound Metabolism in Mammals. Volume 1: A Review of the Literature Published Between 1960 and 1969. London: The Chemical Society, 1970., p. 175

    MAJOR METABOLITES IN A 48-HR URINE SAMPLE FROM RATS GIVEN (14)C-LABELED CHLORPHENESIN CARBAMATE WERE GLUCURONIDE, P-CHLOROPHENOXYLACTIC ACID, P-CHLOROPHENOXYACETIC ACID, & P-CHLOROPHENOL.

    NOZU T ET AL; OYO YAKURI 14(1) 1 (1977)

    5.3 Mechanism of Action

    MUSCLE RELAXANTS CAUSE SKELETAL MUSCULAR RELAXATION, WITHOUT LOSS OF CONSCIOUSNESS, AS RESULT OF SELECTIVE ACTION UPON CNS. ... PROMINENT EFFECT OF MUSCLE RELAXANTS IS TO DEPRESS SPINAL POLYSYNAPTIC REFLEXES PREFERENTIALLY OVER MONOSYNAPTIC REFLEXES. ... MECHANISM OF ACTION...REMAIN TO BE ELUCIDATED. /MUSCLE RELAXANTS/

    Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 239

    Post Enquiry
    POST ENQUIRY